Compare Ambarella Inc (AMBA) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ambarella Inc vs Summit Therapeutics Inc — how do they compare? Ambarella Inc trades at $83.83 (market cap $3.64B), while Summit Therapeutics Inc trades at $15.57 (market cap $12.06B). The key difference: Summit Therapeutics Inc is far larger — about 3.3× Ambarella Inc's market cap, and Ambarella Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| AMBA | SMMT | |
|---|---|---|
Market Cap | $3.64B | $12.06B |
Sector | Technology | Health |
52-Week High | $95.51 | $26.98 |
52-Week Low | $48.65 | $12.55 |
Enterprise Value | $3.37B | $11.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ambarella Inc
Ambarella is a semiconductor company specializing in low-power video compression and computer vision processors. Its chips power AI cameras for security, automotive safety, and robotics applications.
Read more on AMBA →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
